Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | GBA1 | P04062 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13362009 | 1.00 | THRB (0.36) | THRBLMNAGBA1L3MBTL1 | |
| SCHEMBL25592953 | 1.00 | THRB (0.36) | THRBLMNAGBA1L3MBTL1 | |
| SCHEMBL23028656 | 1.00 | THRB (0.36) | THRBLMNAGBA1L3MBTL1 | |
| SCHEMBL13657213 | 1.00 | THRB (0.36) | THRBLMNAGBA1L3MBTL1 | |
| SCHEMBL18683146 | 0.95 | THRB (0.36) | THRBLMNAGBA1L3MBTL1 | |
| SCHEMBL16158586 | 0.95 | THRB (0.36) | THRBLMNAGBA1L3MBTL1 | |
| SCHEMBL9984795 | 0.95 | THRB (0.36) | THRBLMNAGBA1L3MBTL1 | |
| SCHEMBL24038360 | 0.95 | THRB (0.36) | THRBLMNAGBA1L3MBTL1 | |
| SCHEMBL13743009 | 0.83 | THRB (0.38) | THRBLMNA | |
| SCHEMBL13301751 | 0.82 | THRB (0.33) | THRBLMNAGBA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230338501-A1 | LIVE-ATTENUATED RNA HYBRID VACCINE TECHNOLOGY | ACCESS TO ADVANCED HEALTH INSTITUTE | 2023-10-26 | — | — | US | disclosed |
| US-20230310569-A1 | GENETICALLY-ADJUVANTED RNA VACCINES | ACCESS TO ADVANCED HEALTH INSTITUTE | 2023-10-05 | — | — | US | disclosed |
| US-20230310323-A1 | CO-LYOPHILIZED RNA AND NANOSTRUCTURED LIPID CARRIER | ACCESS TO ADVANCED HEALTH INSTITUTE | 2023-10-05 | — | — | US | disclosed |
| US-20230310569-A1 | GENETICALLY-ADJUVANTED RNA VACCINES | ACCESS TO ADVANCED HEALTH INSTITUTE | 2023-10-05 | — | — | US | disclosed |
| US-20230201111-A1 | COMPOSITIONS AND METHODS FOR OPHTHALMIC AND/OR OTHER APPLICATIONS | THE JOHNS HOPKINS UNIVERSITY | 2023-06-29 | — | — | US | disclosed |
| US-11680171-B2 | Self-cleaning, dirt pick-up resistant compositions for roof coatings | HENRY COMPANY, LLC (US) | 2023-06-20 | — | — | US | disclosed |
| US-11642317-B2 | Nanocrystals, compositions, and methods that aid particle transport in mucus | THE JOHNS HOPKINS UNIVERSITY (US) | 2023-05-09 | — | — | US | disclosed |
| US-20220054416-A1 | NANOSTRUCTURED LIPID CARRIERS AND STABLE EMULSIONS AND USES THEREOF | EUAGORE, LLC | 2022-02-24 | — | — | US | disclosed |
| US-11219596-B2 | Compositions and methods for ophthalmic and/or other applications | THE JOHNS HOPKINS UNIVERSITY (US) | 2022-01-11 | — | — | US | disclosed |
| US-11219597-B2 | Compositions and methods for ophthalmic and/or other applications | THE JOHNS HOPKINS UNIVERSITY (US) | 2022-01-11 | — | — | US | disclosed |
| US-20190125758-A1 | COMPOSITIONS AND METHODS FOR OPHTHALMIC AND/OR OTHER APPLICATIONS | THE JOHNS HOPKINS UNIVERSITY | 2019-05-02 | — | — | US | disclosed |
| US-20190111002-A1 | NOVEL VEHICLES FOR THE TRANSFECTION OF miRNAS | UNIVERSIDADE DE SANTIAGO DE COMPOSTELA (ES) | 2019-04-18 | — | — | US | disclosed |
| US-20180064641-A1 | COMPOSITIONS AND METHODS FOR OPHTHALMIC AND/OR OTHER APPLICATIONS | THE JOHNS HOPKINS UNIVERSITY | 2018-03-08 | — | — | US | disclosed |
| US-9827191-B2 | Compositions and methods for ophthalmic and/or other applications | THE JOHNS HOPKINS UNIVERSITY (US) | 2017-11-28 | — | — | US | disclosed |
| US-20170266120-A1 | NANOCRYSTALS, COMPOSITIONS, AND METHODS THAT AID PARTICLE TRANSPORT IN MUCUS | THE JOHNS HOPKINS UNIVERSITY | 2017-09-21 | — | — | US | disclosed |
| US-9737491-B2 | Nanocrystals, compositions, and methods that aid particle transport in mucus | THE JOHNS HOPKINS UNIVERSITY (US) | 2017-08-22 | — | — | US | disclosed |
| US-20170128378-A1 | NANOCRYSTALS, COMPOSITIONS, AND METHODS THAT AID PARTICLE TRANSPORT IN MUCUS | THE JOHNS HOPKINS UNIVERSITY | 2017-05-11 | — | — | US | disclosed |
| US-9513253-B2 | Droplet actuators and techniques for droplet-based enzymatic assays | ADVANCED LIQUID LOGIC, INC. (US) | 2016-12-06 | — | — | US | disclosed |
| US-9513253-B2 | Droplet actuators and techniques for droplet-based enzymatic assays | ADVANCED LIQUID LOGIC, INC. (US) | 2016-12-06 | — | — | US | disclosed |
| US-8992986-B2 | Controlled release of biological entities | AUSTRALIAN NUCLEAR SCIENCE & TECHNOLOGY ORGANISATION (AU) | 2015-03-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (13 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180064641-A1 | COMPOSITIONS AND METHODS FOR OPHTHALMIC AND/OR OTHER APPLICATIONS | MUC1, PDE6C, STRA6 | THRB 4019/4885LMNA 1275/4885GBA1 410/4885 |
| US-20170128378-A1 | NANOCRYSTALS, COMPOSITIONS, AND METHODS THAT AID PARTICLE TRANSPORT IN MUCUS | MUC1, SLC35A1, EPCAM | THRB 4525/4885LMNA 1966/4885GBA1 1169/4885 |
| US-20170266120-A1 | NANOCRYSTALS, COMPOSITIONS, AND METHODS THAT AID PARTICLE TRANSPORT IN MUCUS | MUC1, SLC35A1, EPCAM | THRB 4525/4885LMNA 1966/4885GBA1 1169/4885 |
| US-11219597-B2 | Compositions and methods for ophthalmic and/or other applications | MUC1, PDE6C, STRA6 | THRB 4019/4885LMNA 1275/4885GBA1 410/4885 |
| US-20190125758-A1 | COMPOSITIONS AND METHODS FOR OPHTHALMIC AND/OR OTHER APPLICATIONS | MUC1, PDE6C, STRA6 | THRB 4019/4885LMNA 1275/4885GBA1 410/4885 |
| US-20220054416-A1 | NANOSTRUCTURED LIPID CARRIERS AND STABLE EMULSIONS AND USES THEREOF | LIPC, LIPA, PLA2G2C | THRB 4203/4885LMNA 304/4885GBA1 325/4885 |
| US-20230201111-A1 | COMPOSITIONS AND METHODS FOR OPHTHALMIC AND/OR OTHER APPLICATIONS | MUC1, PDE6C, STRA6 | THRB 4019/4885LMNA 1275/4885GBA1 410/4885 |
| US-11219596-B2 | Compositions and methods for ophthalmic and/or other applications | MUC1, PDE6C, STRA6 | THRB 4019/4885LMNA 1275/4885GBA1 410/4885 |
| US-20230310569-A1 | GENETICALLY-ADJUVANTED RNA VACCINES | TLR3, STING1, TLR9 | THRB 2863/4885LMNA 4561/4885GBA1 646/4885 |
| US-20190111002-A1 | NOVEL VEHICLES FOR THE TRANSFECTION OF miRNAS | TSG101, SLC67A1, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 | THRB 3162/4885LMNA 1877/4885GBA1 1509/4885 |
| US-20230338501-A1 | LIVE-ATTENUATED RNA HYBRID VACCINE TECHNOLOGY | CHIA, SNRPE, LNPK | THRB 4738/4885LMNA 668/4885GBA1 519/4885 |
| US-11642317-B2 | Nanocrystals, compositions, and methods that aid particle transport in mucus | MUC1, SLC35A1, EPCAM | THRB 4525/4885LMNA 1966/4885GBA1 1169/4885 |
| US-20230310323-A1 | CO-LYOPHILIZED RNA AND NANOSTRUCTURED LIPID CARRIER | LIPC, RNMT, RNGTT | THRB 4760/4885LMNA 337/4885GBA1 469/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.